Your browser doesn't support javascript.
loading
Apixaban in patients with atrial fibrillation: patient characteristics of the Latin America cohort from a multinational clinical trial
Avezum, A; Bahit, MC; Hermosillo, JA; Zanetti, FL; Perafan, P; Juarez-Garcia, A; Vulcano, C; Cubillos, LA; Korenblat Donato, BM.
Afiliação
  • Avezum, A; Instituto Dante Pazzanse de Cardiologia. São Paulo. BR
  • Bahit, MC; INECO Neurociencias. Rosario. AR
  • Hermosillo, JA; Insto Nacional de Cardiología. México, DF. MX
  • Zanetti, FL; Universidad de La Frontera. Temuco. CL
  • Perafan, P; Fundación Valle del Lili. Cali. CO
  • Juarez-Garcia, A; Bristol-Myers Squibb Company. México, DF. MX
  • Vulcano, C; Bristol-Myers Squibb. Buenos Aires. AR
  • Cubillos, LA; Pfizer. New Jersey. US
  • Korenblat Donato, BM; Bristol-Myers Squibb. Wallingford. US
Value health ; 18(7): [A809], 2015.
Article em En | SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1068370
Biblioteca responsável: BR79.1
Localização: BR79.1
ABSTRACT
Patients with Atrial fibrillation (AF), have a five-fold increase in the risk of stroke. Treatment for AF include stroke prevention therapy. Vitamin K antagonists (VKAs) have shown to prevent stroke in AF patients. Apixaban, a novel oral direct factor Xa inhibitor was studied in AF patients whom VKA therapy was unsuitable. Apixaban demonstrated clinical benefit in stroke or systemic embolism reduction without impacting the risk of major bleeding or intracranial hemorrhage. Patient characteristics of the Latin America (LA) cohort and overall population are presented.
Assuntos
Buscar no Google
Adicionar na Minha BVS
Imprimir
XML

Coleções: 06-national / BR Base de dados: SES-SP / SESSP-IDPCPROD Assunto principal: Pacientes / Acidente Vascular Cerebral / América Latina Tipo de estudo: Risk_factors_studies Idioma: En Revista: Value health Ano de publicação: 2015 Tipo de documento: Article
Buscar no Google
Adicionar na Minha BVS
Imprimir
XML

Coleções: 06-national / BR Base de dados: SES-SP / SESSP-IDPCPROD Assunto principal: Pacientes / Acidente Vascular Cerebral / América Latina Tipo de estudo: Risk_factors_studies Idioma: En Revista: Value health Ano de publicação: 2015 Tipo de documento: Article